Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | ANPEP | P15144 | 1/20 | 0.52 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.52 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.52 |
| ▸ | CTSK | P43235 | 4/20 | 0.51 |
| ▸ | CTSB | P07858 | 2/20 | 0.50 |
| ▸ | CTSS | P25774 | 2/20 | 0.48 |
| ▸ | CTSL | P07711 | 1/20 | 0.48 |
| ▸ | IDO1 | P14902 | 1/20 | 0.48 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.48 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL355730 | 1.00 | ALDH1A1 (0.53) | ALDH1A1ANPEPRNPEPDNPEPCTSK | |
| SCHEMBL353695 | 1.00 | ALDH1A1 (0.53) | ALDH1A1ANPEPRNPEPDNPEPCTSK | |
| Hydrochloric Acid SCHEMBL7365467 | 0.98 | ALDH1A1 (0.51) | ALDH1A1ANPEPRNPEPDNPEPCTSK | |
| Hydrochloric Acid SCHEMBL1810902 | 0.98 | ALDH1A1 (0.51) | ALDH1A1ANPEPRNPEPDNPEPCTSK | |
| Hydrochloric Acid SCHEMBL9697973 | 0.98 | ALDH1A1 (0.51) | ALDH1A1ANPEPRNPEPDNPEPCTSK | |
| Oxalic Acid SCHEMBL4393417 | 0.95 | ANPEP (0.49) | ALDH1A1ANPEPRNPEPDNPEPCTSK | |
| Oxalic Acid SCHEMBL4393420 | 0.95 | ANPEP (0.49) | ALDH1A1ANPEPRNPEPDNPEPCTSK | |
| Toluene SCHEMBL27746059 | 0.94 | ANPEP (0.48) | ALDH1A1ANPEPRNPEPDNPEPCTSK | |
| Alcohol SCHEMBL28297582 | 0.94 | ANPEP (0.48) | ALDH1A1ANPEPRNPEPDNPEPCTSK | |
| Phenylalanine SCHEMBL11683484 | 0.91 | SLC7A5 (0.61) | ALDH1A1ANPEPRNPEPDNPEPCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 172 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120192379-A | Marine cyclic peptide and synthesis method and application thereof | 内蒙古大学 | 2025-06-24 | — | — | CN | claimed |
| CN-102320950-B | Method for synthesizing acetic acid through carbonylation | SHANGHAI HUAYI GROUP CO | 2015-05-13 | — | — | CN | claimed |
| CN-102250202-B | 1-paranitrophenyl-beta-carboline-3-formyl amine acid carbamates and synthesis method and use thereof | UNIV CAPITAL MEDICAL SCIENCES | 2013-08-28 | — | — | CN | claimed |
| CN-101659607-B | Method for preparing acetic acid and acetic anhydride respectively or synchronously | SHANGHAI COKING & CHEM CORP | 2013-04-10 | — | — | CN | claimed |
| CN-101927201-B | Method for removing impurities from solution of acetic acid and/or acetic anhydride hydroformylation catalyst | SHANGHAI COKING & CHEM CORP | 2012-12-12 | — | — | CN | claimed |
| CN-102241674-B | Synthesis method and antitumor activity evaluation of 1,1-dimethyl-beta-carboline-3-formacyl amino acid benzyl ester | UNIV CAPITAL MEDICAL | 2012-09-12 | — | — | CN | claimed |
| CN-101906102-B | Beta-carboline alkaloid derivative, preparation method and application thereof | UNIV CAPITAL MEDICAL | 2012-08-29 | — | — | CN | claimed |
| CN-102320950-A | Method for synthesizing acetic acid through carbonylation | SHANGHAI HUAYI GROUP CO | 2012-01-18 | — | — | CN | claimed |
| CN-102250202-A | 1-paranitrophenyl-beta-carboline-3-formyl amine acid carbamates and synthesis method and use thereof | UNIV CAPITAL MEDICAL | 2011-11-23 | — | — | CN | claimed |
| CN-102241674-A | Synthesis method and antitumor activity evaluation of 1,1-dimethyl-beta-carboline-3-formacyl amino acid benzyl ester | UNIV CAPITAL MEDICAL | 2011-11-16 | — | — | CN | claimed |
| CN-101658800-B | Catalyst system for use in preparation of acetic acid and acetic anhydride or synchronous preparation of acetic acid and acetic anhydride and preparation method thereof | SHANGHAI COKING & CHEM CORP | 2011-11-02 | — | — | CN | claimed |
| CN-101927201-A | Method for removing impurities from solution of acetic acid and/or acetic anhydride hydroformylation catalyst | SHANGHAI COKING & CHEM CORP | 2010-12-29 | — | — | CN | claimed |
| CN-101497615-B | Substituted purine, preparation and use in medicine | ZHEJIANG MED XINCHANG PHARM | 2010-12-15 | — | — | CN | claimed |
| CN-101906102-A | Beta-carboline alkaloid derivative, preparation method and application thereof | UNIV CAPITAL MEDICAL | 2010-12-08 | — | — | CN | claimed |
| CN-101658800-A | Catalyst system for use in preparation of acetic acid and acetic anhydride or synchronous preparation of acetic acid and acetic anhydride and preparation method thereof | SHANGHAI COKING & CHEMICAL COR | 2010-03-03 | — | — | CN | claimed |
| CN-101659607-A | Method for preparing acetic acid and acetic anhydride respectively or synchronously | SHANGHAI COKING & CHEMICAL COR | 2010-03-03 | — | — | CN | claimed |
| CN-101597290-A | β-Ka Lin-3-formyl tryptophyl amino-acid benzyl ester and its production and application | UNIV CAPITAL MEDICAL (CN) | 2009-12-09 | — | — | CN | claimed |
| CN-101597289-A | 2-tryptophyl-beta-tetrahydro carboline-3-formyol amino-acid benzyl ester and its production and application | UNIV CAPITAL MEDICAL (CN) | 2009-12-09 | — | — | CN | claimed |
| CN-101497615-A | Substituted purine, preparation and use in medicine | XINCHANG PHARMACEUTICAL FACTORY ZHEJIANG MEDICINE CO LTD (CN) | 2009-08-05 | — | — | CN | claimed |
| EP-3364958-B1 | MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USES THEREOF | NAVITOR PHARM INC (US) | 2023-01-04 | — | — | EP | disclosed |
| EP-4112611-A2 | MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USES THEREOF | Navitor Pharmaceuticals, Inc. (US) | 2023-01-04 | — | — | EP | disclosed |
| US-11040939-B1 | N-transfer reagent and method for preparing the same and its application | NATIONAL CHENG KUNG UNIVERSITY (TW) | 2021-06-22 | — | — | US | disclosed |
| CN-111909979-A | Preparation method of L-glufosinate-ammonium | 武汉英凯生物技术研究院有限公司 | 2020-11-10 | — | — | CN | disclosed |
| CN-111748589-A | Preparation method of L-glufosinate-ammonium | 武汉茵茂特生物技术有限公司 | 2020-10-09 | — | — | CN | disclosed |
| CN-106317169-B | Double indoles-dipeptidase derivants, synthesis, antithrombotic acitivity and the application for preparing antithrombotic agents | 首都医科大学 | 2019-07-02 | — | — | CN | disclosed |
| CN-108948138-A | A kind of preparation method of leucine dipeptide | 南京纽邦生物科技有限公司 | 2018-12-07 | — | — | CN | disclosed |
| CN-107501451-A | Chiral CO2Respond ethyleneamino acid polymer and preparation method thereof | 北方民族大学 | 2017-12-22 | — | — | CN | disclosed |
| US-9822146-B2 | Process for the manufacture of degarelix and its intermediates | FERRING B.V. (NL) | 2017-11-21 | — | — | US | disclosed |
| WO-2017070518-A1 | MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USES THEREOF | NAVITOR PHARMACEUTICALS, INC. (US) | 2017-04-27 | — | — | WO | disclosed |
| CN-106349148-A | Novel indoles compound having anti-tumor metastasis activity and anti-inflammatory activity, as well as synthesis and application of novel indoles compound | 首都医科大学 | 2017-01-25 | — | — | CN | disclosed |
| CN-104447394-B | Novel synthesis process of ubenimex | 成都傲飞生物化学品有限责任公司 | 2017-01-18 | — | — | CN | disclosed |
| CN-106317169-A | Bisindole-dipeptide derivatives, synthesis and antithrombotic activity thereof, and application of derivatives in preparation of antithrombotic agents | 首都医科大学 | 2017-01-11 | — | — | CN | disclosed |
| EP-2632935-B1 | PROCESS FOR THE MANUFACTURE OF DEGARELIX AND ITS INTERMEDIATES | FERRING BV (NL) | 2016-09-21 | — | — | EP | disclosed |
| US-20160145301-A1 | PROCESS FOR THE MANUFACTURE OF DEGARELIX AND ITS INTERMEDIATES | FERRING BV (NL) | 2016-05-26 | — | — | US | disclosed |
| US-9175006-B2 | Compositions and methods for cyclofructans as separation agents | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2015-11-03 | — | — | US | disclosed |
| US-9175006-B2 | Compositions and methods for cyclofructans as separation agents | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2015-11-03 | — | — | US | disclosed |
| US-9175006-B2 | Compositions and methods for cyclofructans as separation agents | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2015-11-03 | — | — | US | disclosed |
| US-9090656-B2 | Process for the manufacture of Degarelix and its intermediates | FERRING B.V. (NL) | 2015-07-28 | — | — | US | disclosed |
| CN-103450197-B | Cyclohexyl tetrahydro imidazo pyrido indole-diketone acetyl amino acids, and synthesis, antithrombotic effect and application thereof | UNIV CAPITAL MEDICAL SCIENCES | 2015-07-08 | — | — | CN | disclosed |
| CN-102320950-B | Method for synthesizing acetic acid through carbonylation | SHANGHAI HUAYI GROUP CO | 2015-05-13 | — | — | CN | disclosed |
| US-20140051706-A1 | ALPHA HELIX MIMETICS AND METHODS RELATING THERETO | PRISM PHARMA CO., LTD. (JP) | 2014-02-20 | — | — | US | disclosed |
| CN-103517904-A | Alpha-helix mimetics and methods relating thereto | PRISM BIOLAB CORP | 2014-01-15 | — | — | CN | disclosed |
| EP-2678341-A1 | ALPHA HELIX MIMETICS AND METHODS RELATING THERETO | PRISM Pharma Co., Ltd. (JP) | 2014-01-01 | — | — | EP | disclosed |
| CN-103450197-A | Cyclohexyl tetrahydro imidazo pyrido indole-diketone acetyl amino acids, and synthesis, antithrombotic effect and application thereof | UNIV CAPITAL MEDICAL SCIENCES | 2013-12-18 | — | — | CN | disclosed |
| CN-103435688-A | Novel method for preparing compound of natural glycosyl-1-phosphoryl dipeptide and phosphoramide | UNIV JIANGXI NORMAL SCI & TECH | 2013-12-11 | — | — | CN | disclosed |
| US-20130281661-A1 | PROCESS FOR THE MANUFACTURE OF DEGARELIX AND ITS INTERMEDIATES | FERRING B.V. (NL) | 2013-10-24 | — | — | US | disclosed |
| EP-1619189-B1 | N-(3-acyl-2-hydroxyalkyl) cycloalkyl amide derivatives | SEIKAGAKU KOGYO CO LTD (JP) | 2013-09-04 | — | — | EP | disclosed |
| EP-2632935-A1 | PROCESS FOR THE MANUFACTURE OF DEGARELIX AND ITS INTERMEDIATES | Ferring B.V. (NL) | 2013-09-04 | — | — | EP | disclosed |
| CN-102250202-B | 1-paranitrophenyl-beta-carboline-3-formyl amine acid carbamates and synthesis method and use thereof | UNIV CAPITAL MEDICAL SCIENCES | 2013-08-28 | — | — | CN | disclosed |
| CN-102329376-B | Cyclo(phenylalanine-N-methylleucyl-leucyl-N-methylleucyl-leucyl), and synthesis method and application thereof | UNIV JINAN | 2013-07-10 | — | — | CN | disclosed |
| CN-101090902-B | Cgrp receptor antagonists | MERCK SHARP & DOHME | 2013-05-29 | — | — | CN | disclosed |
| CN-101659607-B | Method for preparing acetic acid and acetic anhydride respectively or synchronously | SHANGHAI COKING & CHEM CORP | 2013-04-10 | — | — | CN | disclosed |
| CN-101927201-B | Method for removing impurities from solution of acetic acid and/or acetic anhydride hydroformylation catalyst | SHANGHAI COKING & CHEM CORP | 2012-12-12 | — | — | CN | disclosed |
| US-20120231972-A1 | Probe Compound for Detecting and Isolating Enzymes and Means and Methods Using the Same | INSTITUTE OF CATALYSIS (CSIC) (ES) | 2012-09-13 | — | — | US | disclosed |
| CN-102241674-B | Synthesis method and antitumor activity evaluation of 1,1-dimethyl-beta-carboline-3-formacyl amino acid benzyl ester | UNIV CAPITAL MEDICAL | 2012-09-12 | — | — | CN | disclosed |
| WO-2012115286-A1 | ALPHA HELIX MIMETICS AND METHODS RELATING THERETO | PRISM BIOLAB CORPORATION (JP) | 2012-08-30 | — | — | WO | disclosed |
| CN-101906102-B | Beta-carboline alkaloid derivative, preparation method and application thereof | UNIV CAPITAL MEDICAL | 2012-08-29 | — | — | CN | disclosed |
| CN-101528673-B | Method for producing asymmetric copper complex crystal | SUMITOMO CO LTD | 2012-08-01 | — | — | CN | disclosed |
| WO-2012055905-A1 | PROCESS FOR THE MANUFACTURE OF DEGARELIX AND ITS INTERMEDIATES | FERRING B.V. (NL) | 2012-05-03 | — | — | WO | disclosed |
| EP-2447276-A1 | Process for the manufacture of Degarelix and its intermediates | Ferring B.V. (NL) | 2012-05-02 | — | — | EP | disclosed |
| US-8153830-B2 | Production method of asymmetric copper complex crystal | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-04-10 | — | — | US | disclosed |
| US-8138370-B2 | Method of producing optically active α-amino acid benzyl esters | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-03-20 | — | — | US | disclosed |
| CN-102329376-A | Cyclo(phenylalanine-N-methylleucyl-leucyl-N-methylleucyl-leucyl), and synthesis method and application thereof | UNIV JINAN | 2012-01-25 | — | — | CN | disclosed |
| CN-102320950-A | Method for synthesizing acetic acid through carbonylation | SHANGHAI HUAYI GROUP CO | 2012-01-18 | — | — | CN | disclosed |
| CN-101565413-B | Isoflavone derivative modified by acetylaminoacid benzyl ester, preparation method and application thereof | PEKING UNIVERSITY (CN) | 2011-12-28 | — | — | CN | disclosed |
| CN-102250202-A | 1-paranitrophenyl-beta-carboline-3-formyl amine acid carbamates and synthesis method and use thereof | UNIV CAPITAL MEDICAL | 2011-11-23 | — | — | CN | disclosed |
| CN-102241674-A | Synthesis method and antitumor activity evaluation of 1,1-dimethyl-beta-carboline-3-formacyl amino acid benzyl ester | UNIV CAPITAL MEDICAL | 2011-11-16 | — | — | CN | disclosed |
| CN-101597290-B | Beta-carboline-3-formyl tryptophyl amine acid carbamate as well as preparation method and application thereof | UNIV CAPITAL MEDICAL | 2011-11-09 | — | — | CN | disclosed |
| CN-101658800-B | Catalyst system for use in preparation of acetic acid and acetic anhydride or synchronous preparation of acetic acid and acetic anhydride and preparation method thereof | SHANGHAI COKING & CHEM CORP | 2011-11-02 | — | — | CN | disclosed |
| US-20110257028-A1 | Method for selectively binding a substrate to sorbents by way of at least bivalent bonds | INSTRACTION GMBH (DE) | 2011-10-20 | — | — | US | disclosed |
| CN-101597289-B | 2-tryptophanyl-Beta-tetrahydric carboline-3-formyol amino-acid benzyl ester and preparation method and application thereof | UNIV CAPITAL MEDICAL | 2011-09-21 | — | — | CN | disclosed |
| CN-101445550-B | Synthetic method of pyroglutamyl small peptide | UNIV XIAMEN | 2011-04-20 | — | — | CN | disclosed |
| US-20110039208-A1 | PHOTORESIST COMPOSITION CONTAINING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-02-17 | — | — | US | disclosed |
| US-20110039208-A1 | PHOTORESIST COMPOSITION CONTAINING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-02-17 | — | — | US | disclosed |
| US-20110024292-A1 | COMPOSITIONS AND METHODS FOR CYCLOFRUCTANS AS SEPARATION AGENTS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2011-02-03 | — | — | US | disclosed |
| US-20110024292-A1 | COMPOSITIONS AND METHODS FOR CYCLOFRUCTANS AS SEPARATION AGENTS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2011-02-03 | — | — | US | disclosed |
| US-20110024292-A1 | COMPOSITIONS AND METHODS FOR CYCLOFRUCTANS AS SEPARATION AGENTS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2011-02-03 | — | — | US | disclosed |
| CN-101927201-A | Method for removing impurities from solution of acetic acid and/or acetic anhydride hydroformylation catalyst | SHANGHAI COKING & CHEM CORP | 2010-12-29 | — | — | CN | disclosed |
| CN-101497615-B | Substituted purine, preparation and use in medicine | ZHEJIANG MED XINCHANG PHARM | 2010-12-15 | — | — | CN | disclosed |
| CN-101906102-A | Beta-carboline alkaloid derivative, preparation method and application thereof | UNIV CAPITAL MEDICAL | 2010-12-08 | — | — | CN | disclosed |
| WO-2010105851-A1 | PROBE COMPOUND FOR DETECTING AND ISOLATING ENZYMES AND MEANS AND METHODS USING THE SAME | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2010-09-23 | — | — | WO | disclosed |
| US-20100094036-A1 | PRODUCTION METHOD OF ASYMMETRIC COPPER COMPLEX CRYSTAL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-04-15 | — | — | US | disclosed |
| CN-101658800-A | Catalyst system for use in preparation of acetic acid and acetic anhydride or synchronous preparation of acetic acid and acetic anhydride and preparation method thereof | SHANGHAI COKING & CHEMICAL COR | 2010-03-03 | — | — | CN | disclosed |
| CN-101659607-A | Method for preparing acetic acid and acetic anhydride respectively or synchronously | SHANGHAI COKING & CHEMICAL COR | 2010-03-03 | — | — | CN | disclosed |
| US-20100010254-A1 | METHOD OF PRODUCING OPTICALLY ACTIVE ALPHA-AMINO ACID BENZYL ESTERS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-01-14 | — | — | US | disclosed |
| CN-101597290-A | β-Ka Lin-3-formyl tryptophyl amino-acid benzyl ester and its production and application | UNIV CAPITAL MEDICAL (CN) | 2009-12-09 | — | — | CN | disclosed |
| CN-101597289-A | 2-tryptophyl-beta-tetrahydro carboline-3-formyol amino-acid benzyl ester and its production and application | UNIV CAPITAL MEDICAL (CN) | 2009-12-09 | — | — | CN | disclosed |
| US-7625870-B2 | Peptide substance restoring respiratory organs function | “Access Bioscience” CJSC (RU) | 2009-12-01 | — | — | US | disclosed |
| CN-101565413-A | Isoflavone derivative modified by acetylaminoacid benzyl ester, preparation method and application thereof | UNIV BEIJING (CN) | 2009-10-28 | — | — | CN | disclosed |
| CN-101528673-A | Method for producing asymmetric copper complex crystal | SUMITOMO CHEMICAL CO (JP) | 2009-09-09 | — | — | CN | disclosed |
| CN-101511776-A | Process for production of optically active alpha-amino acid benzyl ester | SUMITOMO CHEMICAL CO (JP) | 2009-08-19 | — | — | CN | disclosed |
| CN-101497615-A | Substituted purine, preparation and use in medicine | XINCHANG PHARMACEUTICAL FACTORY ZHEJIANG MEDICINE CO LTD (CN) | 2009-08-05 | — | — | CN | disclosed |
| EP-2078710-A1 | METHOD FOR PRODUCING ASYMMETRIC COPPER COMPLEX CRYSTAL | Sumitomo Chemical Company, Limited (JP) | 2009-07-15 | — | — | EP | disclosed |
| CN-101445550-A | Synthetic method of pyroglutamyl small peptide | UNIV XIAMEN (CN) | 2009-06-03 | — | — | CN | disclosed |
| EP-2062873-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE ALPHA-AMINO ACID BENZYL ESTER | Sumitomo Chemical Company, Limited (JP) | 2009-05-27 | — | — | EP | disclosed |
| WO-2008134429-A1 | CYSTEINE PROTEINASE INHIBITORS AND USES THEREOF | THE SCRIPPS RESEARCH INSTITUTE (US) | 2008-11-06 | — | — | WO | disclosed |
| US-20080274982-A1 | Peptide Substance Restoring Respiratory Organs Function | "ACCESS BIOSCIENCE" CJSC (RU) | 2008-11-06 | — | — | US | disclosed |
| EP-1758922-B8 | PEPTIDE SUBSTANCE RESTORING FUNCTION OF RESPIRATORY ORGANS | ACCESS BIOSCIENCE CJSC (RU) | 2008-05-07 | — | — | EP | disclosed |
| EP-1758922-B1 | PEPTIDE SUBSTANCE RESTORING FUNCTION OF RESPIRATORY ORGANS | SANKT PETERBURGSKAYA OBSCHESTV (RU) | 2008-02-13 | — | — | EP | disclosed |
| CN-101090902-A | Cgrp receptor antagonists | MERCK & CO INC (US) | 2007-12-19 | — | — | CN | disclosed |
| US-7262169-B1 | Process for preparing peptide intermediates | MERCK & CO., INC. (US) | 2007-08-28 | — | — | US | disclosed |
| EP-1758922-A1 | PEPTIDE SUBSTANCE RESTORING FUNCTION OF RESPIRATORY ORGANS | SANKT-PETERBURGSKAYA OBSCHESTVENNAYA ORGANIZATSIYA "SANKT-PETERBURGSKIY INSTITUT BIOREGULYATSII I GERONTOLOGII SZO RAMN" (RU) | 2007-03-07 | — | — | EP | disclosed |
| EP-1008592-B1 | Cyclic amide derivatives which inhibit cathepsin K | SEIKAGAKU KOGYO CO LTD (JP) | 2006-02-01 | — | — | EP | disclosed |
| EP-1619189-A1 | N-(3-acyl-2-hydroxyalkyl) cycloalkyl amide derivatives | SEIKAGAKU CORPORATION (JP) | 2006-01-25 | — | — | EP | disclosed |
| EP-1616867-A1 | Hydroxycarboxylic acid derivatives | SEIKAGAKU CORPORATION (JP) | 2006-01-18 | — | — | EP | disclosed |
| EP-1616859-A1 | Substituted cyclohexyl carboxylic acid compounds | SEIKAGAKU CORPORATION (JP) | 2006-01-18 | — | — | EP | disclosed |
| WO-2006001729-A1 | PEPTIDE SUBSTANCE RESTORING RESPIRATORY ORGANS FUNCTION | SANKT-PETERBURGSKAYA OBSCHESTVENNAYA ORGANIZATSIYA 'INSTITUT BIOREGULYATSII I GERONTOLOGII CZO RAMN' (RU) | 2006-01-05 | — | — | WO | disclosed |
| US-6713502-B2 | HEPATITIS C VIRUS INHIBITORS | SMITHKLINE BEECHAM CORPORATION | 2004-03-30 | — | — | US | disclosed |
| WO-2004011473-A1 | ORGANOGERMANIUM COMPOUNDS AND METHODS FOR THEIR USE | CHIROGEN PTY LIMITED (AU) | 2004-02-05 | — | — | WO | disclosed |
| US-20040010030-A1 | NOVEL ANTI-INFECTIVES | SMITHKLINE BEECHAM CORPORATION | 2004-01-15 | — | — | US | disclosed |
| US-20030133927-A1 | Conjugates useful in the treatment of prostate cancer | DEFEO-JONES DEBORAH (US) | 2003-07-17 | — | — | US | disclosed |
| EP-1226158-B1 | PROCESS FOR PREPARING PEPTIDE INTERMEDIATES | MERCK SHARP & DOHME (GB) | 2003-07-02 | — | — | EP | disclosed |
| EP-1278743-A4 | NOVEL ANTI-INFECTIVES | SMITHKLINE BEECHAM CORP (US) | 2003-05-14 | — | — | EP | disclosed |
| US-6552166-B1 | Oligopeptide is mixed with a salt of the anthracycline antibiotic in the presence of a carboxyl activating agent and a base | MERCK & CO., INC. | 2003-04-22 | — | — | US | disclosed |
| US-6552076-B2 | Anticarcinogenic agents; controlling apoptosis | MITOKOR | 2003-04-22 | — | — | US | disclosed |
| EP-1278743-A1 | NOVEL ANTI-INFECTIVES | SmithKline Beecham Corporation (US) | 2003-01-29 | — | — | EP | disclosed |
| US-20020173543-A1 | Compounds for altering mitochondrial function and cellular responses | MITOKOR | 2002-11-21 | — | — | US | disclosed |
| US-6458781-B1 | BLOCKERS CALCIUM CHANNEL ANTAGONISTS FOR STROKES, BRAIN DISORDERS | WARNER-LAMBERT COMPANY | 2002-10-01 | — | — | US | disclosed |
| EP-1226158-A1 | PROCESS FOR PREPARING PEPTIDE INTERMEDIATES | MERCK SHARP & DOHME LTD. (GB) | 2002-07-31 | — | — | EP | disclosed |
| EP-1225918-A2 | CONJUGATES USEFUL IN THE TREATMENT OF PROSTATE CANCER | Merck & Co., Inc. (US) | 2002-07-31 | — | — | EP | disclosed |
| US-6423689-B1 | Peptidyl calcium channel blockers | WARNER-LAMBERT COMPANY | 2002-07-23 | — | — | US | disclosed |
| WO-2002048092-A2 | COMPOUNDS FOR ALTERING MITOCHONDRIAL FUNCTION AND CELLULAR RESPONSES | MITOKOR (US) | 2002-06-20 | — | — | WO | disclosed |
| WO-2002039997-A2 | ACE-2 MODULATING COMPOUNDS AND USE THEREOF | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2002-05-23 | — | — | WO | disclosed |
| US-20020042375-A1 | Method of treating cancer | HEIMBROOK DAVID C (US) | 2002-04-11 | — | — | US | disclosed |
| US-20020041880-A1 | Method of treating cancer | DEFEO-JONES DEBORAH (US) | 2002-04-11 | — | — | US | disclosed |
| US-6362174-B1 | ANALGESICS, ANTIISCHEMIC AGENTS, ANTIEOILEPTIC AGENTS | WARNER-LAMBERT COMPANY | 2002-03-26 | — | — | US | disclosed |
| US-6355611-B1 | SODIUM SALT OF PROSTATE SPECIFIC ANTIGEN CONJUGATE COMPOUND; USEFUL IN TREATMENT OF PROSTATE CANCER AND BENIGN PROSTATIC HYPERPLASIA | MERCK & CO., INC. | 2002-03-12 | — | — | US | disclosed |
| US-20020028801-A1 | Reduced dipeptide analogues as calcium channel antagonitsts | RAFFERTY MICHAEL FRANCIS (US) | 2002-03-07 | — | — | US | disclosed |
| WO-2001085720-A1 | NOVEL ANTI-INFECTIVES | SMITHKLINE BEECHAM CORPORATION (US) | 2001-11-15 | — | — | WO | disclosed |
| US-6316440-B1 | TREATMENT OF STROKE, HEAD TRAUMA, CEREBRAL ISCHEMIA, PAIN AND EPILEPSY | WARNER-LAMBERT COMPANY | 2001-11-13 | — | — | US | disclosed |
| EP-1135398-A1 | CYANOPHOSPHONAMIDES AND METHOD FOR PREPARATION | Monsanto Technology LLC (US) | 2001-09-26 | — | — | EP | disclosed |
| WO-2001029065-A1 | PROCESS FOR PREPARING PEPTIDE INTERMEDIATES | MERCK SHARP & DOHME LIMITED (GB) | 2001-04-26 | — | — | WO | disclosed |
| WO-2001028593-A2 | CONJUGATES USEFUL IN THE TREATMENT OF PROSTATE CANCER | MERCK & CO., INC. (US) | 2001-04-26 | — | — | WO | disclosed |
| US-6218563-B1 | Cyanophosphonamides and method for preparation | MONSANTO COMPANY | 2001-04-17 | — | — | US | disclosed |
| US-6117870-A | USEFUL AS THERAPEUTIC DRUG OR PREVENTIVE DRUG OF ARTHRITIS AND RHEUMATISM DUE TO INCREASE OF BONE RESORPTION IN ADDITION TO BONE DISEASES SUCH AS OSTEOPOROSIS, HYPERCALCEMIA, AND PAGET'S DISEASE | FUJIREBIO KABUSHIKI KAISHA (JP) | 2000-09-12 | — | — | US | disclosed |
| EP-1008592-A2 | Cyclic amide derivatives which inhibit cathepsin K | Fujirebio Kabushiki Kaisha (JP) | 2000-06-14 | — | — | EP | disclosed |
| WO-2000032611-A1 | CYANOPHOSPHONAMIDES AND METHOD FOR PREPARATION | MONSANTO TECHNOLOGY LLC (US) | 2000-06-08 | — | — | WO | disclosed |
| WO-2000006559-A1 | REDUCED DIPEPTIDE ANALOGUES AS CALCIUM CHANNEL ANTAGONISTS | WARNER-LAMBERT COMPANY (US) | 2000-02-10 | — | — | WO | disclosed |
| WO-1999055688-A1 | SUBSTITUTED DIARYLALKYL AMIDES AS CALCIUM CHANNEL ANTAGONISTS | WARNER-LAMBERT COMPANY (US) | 1999-11-04 | — | — | WO | disclosed |
| EP-0948506-A1 | CYANOPHOSPHONATE DERIVATIVES | MONSANTO COMPANY (US) | 1999-10-13 | — | — | EP | disclosed |
| EP-0948502-A1 | CYANOPHOSPHORUS COMPOUNDS AND THEIR PREPARATION | MONSANTO COMPANY (US) | 1999-10-13 | — | — | EP | disclosed |
| EP-0941233-A2 | ANTIVIRAL PEPTIDE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 1999-09-15 | — | — | EP | disclosed |
| US-5945082-A | HERBICIDES, INSECTICIDES, FLAME RETARDANTS, PLASTICIZERS; CYANATION, SALT FORMATION, PHOSPHONATION, PHOSPHATING | MONSANTO COMPANY (US) | 1999-08-31 | — | — | US | disclosed |
| US-5935542-A | Cyanphosphonate derivatives and method for their preparation | MONSANTO COMPANY (US) | 1999-08-10 | — | — | US | disclosed |
| WO-1998029419-A1 | CYANOPHOSPHORUS COMPOUNDS AND THEIR PREPARATION | MONSANTO COMPANY (US) | 1998-07-09 | — | — | WO | disclosed |
| WO-1998029422-A1 | CYANOPHOSPHONATE DERIVATIVES | MONSANTO COMPANY (US) | 1998-07-09 | — | — | WO | disclosed |
| WO-1998022496-A2 | ANTIVIRAL PEPTIDE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 1998-05-28 | — | — | WO | disclosed |
| US-5719296-A | THERAPY, PREVENTION OF AUTOIMMUNE DISEASES; PREVENTS PEPTIDE BINDING TO MAJOR HISTOCOMPATBILITY COMPLEX PROTEINS | MERCK & CO., INC. (US) | 1998-02-17 | — | — | US | disclosed |
| WO-1997016425-A1 | NOVEL INHIBITORS OF PEPTIDE BINDING TO MHC CLASS II PROTEINS | MERCK & CO., INC. (US) | 1997-05-09 | — | — | WO | disclosed |
| EP-0671911-A4 | CARBOXY-PEPTIDYL DERIVATIVES AS ANTIDEGENERATIVE ACTIVE AGENTS. | MERCK & CO INC (US) | 1996-08-21 | — | — | EP | disclosed |
| EP-0671911-A1 | CARBOXY-PEPTIDYL DERIVATIVES AS ANTIDEGENERATIVE ACTIVE AGENTS | MERCK & CO. INC. (US) | 1995-09-20 | — | — | EP | disclosed |
| WO-1995008550-A1 | ENDOTHELIN ANTAGONISTS | ABBOTT LABORATORIES (US) | 1995-03-30 | — | — | WO | disclosed |
| WO-1994012169-A1 | CARBOXY-PEPTIDYL DERIVATIVES AS ANTIDEGENERATIVE ACTIVE AGENTS | MERCK & CO., INC. (US) | 1994-06-09 | — | — | WO | disclosed |
| EP-0320118-B1 | PEPTIDES WITH COLLAGENASE INHIBITING ACTIVITY | BEECHAM GROUP PLC (GB) | 1993-06-02 | — | — | EP | disclosed |
| WO-1993000359-A1 | MODIFIED PEPTIDES TRANSPORTABLE INTO THE CENTRAL NERVOUS SYSTEM | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1993-01-07 | — | — | WO | disclosed |
| EP-0253882-A4 | ACYLATED CYANAMIDE COMPOSITION. | UNIV MINNESOTA (US) | 1990-06-27 | — | — | EP | disclosed |
| US-4935404-A | ANTIARTHRITIC AGENTS; RHEUMATIC DISEASES | BEECHAM GROUP P.L.C. OF BEECHAM HOUSE (GB) | 1990-06-19 | — | — | US | disclosed |
| EP-0320118-A2 | Peptides with collagenase inhibiting activity | BEECHAM GROUP PLC (GB) | 1989-06-14 | — | — | EP | disclosed |
| EP-0126974-B1 | CARBOXYALKYL PEPTIDE DERIVATIVES | G.D. Searle & Co. (US) | 1988-06-15 | — | — | EP | disclosed |
| EP-0253882-A1 | ACYLATED CYANAMIDE COMPOSITION | THE REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1988-01-27 | — | — | EP | disclosed |
| WO-1987004348-A1 | ACYLATED CYANAMIDE COMPOSITION | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1987-07-30 | — | — | WO | disclosed |
| EP-0098865-A4 | PEPTIDE SYNTHESIS AND AMINO ACID BLOCKING AGENTS. | RESEARCH CORP (US) | 1986-11-20 | — | — | EP | disclosed |
| US-4581167-A | DIPEPTIDE INTERMEDIATE | RESEARCH CORPORATION (US) | 1986-04-08 | — | — | US | disclosed |
| US-4568666-A | COLLAGENASE INHIBITORS, ANTIARTJRITIC AGENTS | G. D. SEARLE & CO. (US) | 1986-02-04 | — | — | US | disclosed |
| US-4511504-A | COLLAGENASE INHIBITORS | G.D. SEARLE & CO. (US) | 1985-04-16 | — | — | US | disclosed |
| US-4508657-A | Peptide synthesis and amino acid blocking agents | RESEARCH CORPORATION (US) | 1985-04-02 | — | — | US | disclosed |
| EP-0126974-A1 | Carboxyalkyl peptide derivatives | G.D. Searle & Co. (US) | 1984-12-05 | — | — | EP | disclosed |
| US-4460503-A | OLIGO AND POLYPEPTIDES | INSTITUT PASTEUR (FR) | 1984-07-17 | — | — | US | disclosed |
| EP-0098865-A1 | PEPTIDE SYNTHESIS AND AMINO ACID BLOCKING AGENTS. | RESEARCH CORP (US) | 1984-01-25 | — | — | EP | disclosed |
| WO-1983002448-A1 | PEPTIDE SYNTHESIS AND AMINO ACID BLOCKING AGENTS | RESEARCH CORP (US) | 1983-07-21 | — | — | WO | disclosed |
| US-4394519-A | N-(INDENYLMETHOXYCARBONYL) AMINO ACIDS | RESEARCH CORPORATION (US) | 1983-07-19 | — | — | US | disclosed |
| US-4064236-A | Peptide carbazates and pharmaceutical composition | MERCK & CO., INC. (US) | 1977-12-20 | — | — | US | disclosed |
| US-4064236-A | Peptide carbazates and pharmaceutical composition | MERCK & CO., INC. (US) | 1977-12-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (16 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020173543-A1 | Compounds for altering mitochondrial function and cellular responses | UQCRC1, UQCRC2, NDUFAB1 | ALDH1A1 1003/4885ANPEP 4782/4885RNPEP 4450/4885 |
| US-20030133927-A1 | Conjugates useful in the treatment of prostate cancer | BCL2, BCL2L10, BCL2L13 | ALDH1A1 3095/4885ANPEP 148/4885RNPEP 145/4885 |
| US-20110257028-A1 | Method for selectively binding a substrate to sorbents by way of at least bivalent bonds | SPR, ABCG2, SHBG | ALDH1A1 2479/4885ANPEP 1844/4885RNPEP 998/4885 |
| US-20020042375-A1 | Method of treating cancer | ACP3, KLK3, FOLH1 | ALDH1A1 86/4885ANPEP 352/4885RNPEP 508/4885 |
| US-20110024292-A1 | COMPOSITIONS AND METHODS FOR CYCLOFRUCTANS AS SEPARATION AGENTS | PAICS, DCXR, PFAS | ALDH1A1 1565/4885ANPEP 448/4885RNPEP 712/4885 |
| US-20140051706-A1 | ALPHA HELIX MIMETICS AND METHODS RELATING THERETO | COL1A1, PLOD3, THPO | ALDH1A1 1615/4885ANPEP 3146/4885RNPEP 3245/4885 |
| US-20160145301-A1 | PROCESS FOR THE MANUFACTURE OF DEGARELIX AND ITS INTERMEDIATES | VIP, HABP2, DPP9 | ALDH1A1 2182/4885ANPEP 5/4885RNPEP 56/4885 |
| US-11040939-B1 | N-transfer reagent and method for preparing the same and its application | DNTT, NNMT, NMT1 | ALDH1A1 1050/4885ANPEP 201/4885RNPEP 264/4885 |
| US-20020028801-A1 | Reduced dipeptide analogues as calcium channel antagonitsts | CACNA1E, RYR1, CACNA1B | ALDH1A1 3308/4885ANPEP 676/4885RNPEP 1628/4885 |
| US-20120231972-A1 | Probe Compound for Detecting and Isolating Enzymes and Means and Methods Using the Same | SI, GUSB, MPI | ALDH1A1 194/4885ANPEP 32/4885RNPEP 93/4885 |
| US-20080274982-A1 | Peptide Substance Restoring Respiratory Organs Function | GLUL, ENPEP, VIP | ALDH1A1 1863/4885ANPEP 9/4885RNPEP 20/4885 |
| US-20130281661-A1 | PROCESS FOR THE MANUFACTURE OF DEGARELIX AND ITS INTERMEDIATES | HM13, HABP2, DPP9 | ALDH1A1 2110/4885ANPEP 10/4885RNPEP 66/4885 |
| US-20100094036-A1 | PRODUCTION METHOD OF ASYMMETRIC COPPER COMPLEX CRYSTAL | ADH1A, ADH1C, ALDH3A1 | ALDH1A1 31/4885ANPEP 1858/4885RNPEP 878/4885 |
| US-20100010254-A1 | METHOD OF PRODUCING OPTICALLY ACTIVE ALPHA-AMINO ACID BENZYL ESTERS | BCAT1, BCAT2, AADAT | ALDH1A1 186/4885ANPEP 19/4885RNPEP 63/4885 |
| US-20040010030-A1 | NOVEL ANTI-INFECTIVES | CTSL, MMP8, SERPINB1 | ALDH1A1 4350/4885ANPEP 751/4885RNPEP 286/4885 |
| US-20020041880-A1 | Method of treating cancer | ACP3, FOLH1, KLK3 | ALDH1A1 296/4885ANPEP 223/4885RNPEP 298/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.